A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

NCT00240708 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: risperidone

Sponsor

Janssen Pharmaceutical K.K.